2026 NPPES data Internal Medicine Physician NPI 1942254891 MD
Verify on CMS →

RASIKLAL DELVADIA, MD

Internal Medicine Physician in TITUSVILLE, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
7K
Medicare Part D claims · 754 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

RASIKLAL DELVADIA, MD filed 7,254 Medicare Part D claims in 2023 as a Internal Medicine Physician in TITUSVILLE, Florida, prescribing 88% generic.

7K
Part D claims, 2023
88%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RASIKLAL DELVADIA, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

7,254 Top 3% higher than 97% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

RASIKLAL DELVADIA, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about RASIKLAL DELVADIA, MD?

Quality data not reported

NPI registry status

Active

Issued 05/22/2006

NPI 1942254891

Primary specialty

Internal Medicine Physician

High-volume

172,858 US NPIs in this specialty

Medicare Part D claims

7,254 167% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

Specialty distribution in Florida

How Internal Medicine Physician compares to other specialties among Florida providers

Florida providers

Internal Medicine Physician share within Florida

1. Internal Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Internal Medicine Physician share within Florida

Specialty board-certification context

Estimated specialty board-certified rate — Internal Medicine Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Internal Medicine Physician ABMS/AOA estimate

Est. board-certified rate (Internal Medicine Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Internal Medicine Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RASIKLAL DELVADIA, MD appears in the CMS NPPES registry as a Internal Medicine Physician provider holding MD credentials at 2185A CHENEY HWY, TITUSVILLE, FL, 32780, with a listed phone of (321) 269-9800. NPI 1942254891 was issued on 05/22/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DELVADIA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 7,254 prescription claims written by this provider, covering 754 Medicare beneficiaries and totaling roughly $676K in drug spend, split 12% brand-name and 88% generic by claim count, with an opioid prescribing rate of 0.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2185A CHENEY HWY
TITUSVILLE, FL 32780

Provider Details

NPI 1942254891
Specialty Internal Medicine Physician
Credentials MD
Gender Male
NPI Issued 05/22/2006

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to RASIKLAL DELVADIA, MD. To verify RASIKLAL DELVADIA, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

RASIKLAL DELVADIA, MD — brand share 12.0%
Specialty average (est.)

12% brand-name claims vs 88% generic, on 7,254 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

7,254
Total Claims
$676K
Total Drug Cost
754
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
17,570
Total Day Supply
517,839
Brand vs Generic
12% brand / 88% generic
Brand Drug Cost
$540K
Generic Drug Cost
$128K
Opioid Claims
27 (0.4% rate)
Antibiotic Claims
187

Patient Demographics

Average Patient Age
75.9 years
Avg HCC Risk Score
1.29
Gender Split
58% female / 42% male
Age Distribution
<65: 34, 65-74: 298, 75-84: 301, 85+: 121

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What RASIKLAL DELVADIA, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Amlodipine Besylate
493
Atorvastatin Calcium
372
Rosuvastatin Calcium
363
Levothyroxine Sodium
345
Losartan Potassium
318
Lisinopril
229
Metformin Hcl
198
Gabapentin
180
Omeprazole
175
Losartan-Hydrochlorothiazide
Losartan/Hydrochlorothiazide
162

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How RASIKLAL DELVADIA, MD fits within the Internal Medicine Physician landscape nationally.

172,858
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

RASIKLAL DELVADIA, MD's 7,254 claims are above the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as DELVADIA.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RASIKLAL DELVADIA, MD's specialty?
RASIKLAL DELVADIA, MD specializes in Internal Medicine Physician and practices in TITUSVILLE, Florida. Credentials: MD.
How much does RASIKLAL DELVADIA, MD prescribe under Medicare Part D?
In 2023, RASIKLAL DELVADIA, MD wrote 7,254 Medicare Part D claims totaling $676K in drug costs for 754 beneficiaries.
Where is RASIKLAL DELVADIA, MD located?
RASIKLAL DELVADIA, MD is located at 2185A CHENEY HWY, TITUSVILLE, FL, 32780. Phone: (321) 269-9800.
What is RASIKLAL DELVADIA, MD's NPI number?
RASIKLAL DELVADIA, MD's National Provider Identifier (NPI) is 1942254891, issued on 05/22/2006.
Does RASIKLAL DELVADIA, MD prescribe more brand-name or generic drugs?
RASIKLAL DELVADIA, MD's prescribing is 12% brand-name and 88% generic drugs by claim count, with $540K in brand drug costs.
Does RASIKLAL DELVADIA, MD prescribe opioids?
Yes, RASIKLAL DELVADIA, MD had 27 opioid claims in 2023 with an opioid prescribing rate of 0.4%.
How many Internal Medicine Physician providers are there in the US?
There are 172,858 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does RASIKLAL DELVADIA, MD prescribe most often?
Based on 2023 Medicare Part D data, RASIKLAL DELVADIA, MD's most frequently prescribed drugs include Amlodipine Besylate, Atorvastatin Calcium, Rosuvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RASIKLAL DELVADIA, MD accept Medicare?
RASIKLAL DELVADIA, MD appears in CMS Medicare data with 7,254 Part D claims and 754 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RASIKLAL DELVADIA, MD's credentials?
RASIKLAL DELVADIA, MD's NPI is 1942254891 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology